APA (7th ed.) Citation

Vasudevan Mani, Syed Imam Rabbani, Ali Shariq, Palanisamy Amirthalingam, & Minhajul Arfeen. (2022). Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats. MDPI AG.

Chicago Style (17th ed.) Citation

Vasudevan Mani, Syed Imam Rabbani, Ali Shariq, Palanisamy Amirthalingam, and Minhajul Arfeen. Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats. MDPI AG, 2022.

MLA (9th ed.) Citation

Vasudevan Mani, et al. Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats. MDPI AG, 2022.